These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34417833)

  • 1. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
    Alhalabi KT; Stichel D; Sievers P; Peterziel H; Sommerkamp AC; Sturm D; Wittmann A; Sill M; Jäger N; Beck P; Pajtler KW; Snuderl M; Jour G; Delorenzo M; Martin AM; Levy A; Dalvi N; Hansford JR; Gottardo NG; Uro-Coste E; Maurage CA; Godfraind C; Vandenbos F; Pietsch T; Kramm C; Filippidou M; Kattamis A; Jones C; Øra I; Mikkelsen TS; Zapotocky M; Sumerauer D; Scheie D; McCabe M; Wesseling P; Tops BBJ; Kranendonk MEG; Karajannis MA; Bouvier N; Papaemmanuil E; Dohmen H; Acker T; von Hoff K; Schmid S; Miele E; Filipski K; Kitanovski L; Krskova L; Gojo J; Haberler C; Alvaro F; Ecker J; Selt F; Milde T; Witt O; Oehme I; Kool M; von Deimling A; Korshunov A; Pfister SM; Sahm F; Jones DTW
    Acta Neuropathol; 2021 Nov; 142(5):841-857. PubMed ID: 34417833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions.
    Tauziède-Espariat A; Chotard G; le Loarer F; Baud J; Azmani R; Dangouloff-Ros V; Boddaert N; Icher-de-Bouyn C; Gimbert E; Hasty L; Métais A; Chrétien F; Varlet P;
    Acta Neuropathol Commun; 2022 Feb; 10(1):15. PubMed ID: 35115049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity.
    Siegfried A; Rousseau A; Maurage CA; Pericart S; Nicaise Y; Escudie F; Grand D; Delrieu A; Gomez-Brouchet A; Le Guellec S; Franchet C; Boetto S; Vinchon M; Sol JC; Roux FE; Rigau V; Bertozzi AI; Jones DTW; Figarella-Branger D; Uro-Coste E
    Brain Pathol; 2019 Jan; 29(1):53-62. PubMed ID: 29679497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polyphenotypic malignant paediatric brain tumour presenting a MN1-PATZ1 fusion, no epigenetic similarities with CNS High-Grade Neuroepithelial Tumour with MN1 Alteration (CNS HGNET-MN1) and related to PATZ1-fused sarcomas.
    Burel-Vandenbos F; Pierron G; Thomas C; Reynaud S; Gregoire V; Duhil de Benaze G; Croze S; Chivoret N; Honavar M; Figarella-Branger D; Maurage CA; Pedeutour F; Hasselblatt M; Godfraind C
    Neuropathol Appl Neurobiol; 2020 Aug; 46(5):506-509. PubMed ID: 32397004
    [No Abstract]   [Full Text] [Related]  

  • 5. A rare case of paediatric astroblastoma with concomitant MN1-GTSE1 and EWSR1-PATZ1 gene fusions altering management.
    Chadda KR; Holland K; Scoffings D; Dean A; Pickles JC; Behjati S; Jacques TS; Trotman J; Tarpey P; Allinson K; Murray MJ;
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):882-888. PubMed ID: 33534137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The spectrum of rare central nervous system (CNS) tumors with EWSR1-non-ETS fusions: experience from three pediatric institutions with review of the literature.
    Lopez-Nunez O; Cafferata B; Santi M; Ranganathan S; Pearce TM; Kulich SM; Bailey KM; Broniscer A; Rossi S; Zin A; Nasrallah MP; Li MM; Zhong Y; Miele E; Alaggio R; Surrey LF
    Brain Pathol; 2021 Jan; 31(1):70-83. PubMed ID: 32997853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted fusion analysis can aid in the classification and treatment of pediatric glioma, ependymoma, and glioneuronal tumors.
    Lake JA; Donson AM; Prince E; Davies KD; Nellan A; Green AL; Mulcahy Levy J; Dorris K; Vibhakar R; Hankinson TC; Foreman NK; Ewalt MD; Kleinschmidt-DeMasters BK; Hoffman LM; Gilani A
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28028. PubMed ID: 31595628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases.
    Rossi S; Barresi S; Colafati GS; Genovese S; Tancredi C; Costabile V; Patrizi S; Giovannoni I; Asioli S; Poliani PL; Gardiman MP; Cardoni A; Del Baldo G; Antonelli M; Gianno F; Piccirilli E; Catino G; Martucci L; Quacquarini D; Toni F; Melchionda F; Viscardi E; Zucchelli M; Dal Pos S; Gatti E; Liserre R; Schiavello E; Diomedi-Camassei F; Carai A; Mastronuzzi A; Gessi M; Giannini C; Novelli A; Onetti Muda A; Miele E; Alesi V; Alaggio R
    Mod Pathol; 2024 Feb; 37(2):100387. PubMed ID: 38007157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroepithelial tumor with EWSR1::PATZ1 fusion: A literature review.
    Kim H; Lee K; Phi JH; Paek SH; Yun H; Choi SH; Park SH
    J Neuropathol Exp Neurol; 2023 Oct; 82(11):934-947. PubMed ID: 37804108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma.
    Bridge JA; Sumegi J; Druta M; Bui MM; Henderson-Jackson E; Linos K; Baker M; Walko CM; Millis S; Brohl AS
    Mod Pathol; 2019 Nov; 32(11):1593-1604. PubMed ID: 31189996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early ependymal tumor with MN1-BEND2 fusion: a mostly cerebral tumor of female children with a good prognosis that is distinct from classical astroblastoma.
    Lehman NL
    J Neurooncol; 2023 Feb; 161(3):425-439. PubMed ID: 36604386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma.
    Al-Obaidy KI; Bridge JA; Cheng L; Sumegi J; Reuter VE; Benayed R; Hameed M; Williamson SR; Hes O; Alruwaii FI; Segal JP; Wanjari P; Idrees MT; Nassiri M; Eble JN; Grignon DJ
    Mod Pathol; 2021 Oct; 34(10):1921-1934. PubMed ID: 34099871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary glioneuronal tumor (PGNT) exhibits a characteristic methylation profile and fusions involving PRKCA.
    Hou Y; Pinheiro J; Sahm F; Reuss DE; Schrimpf D; Stichel D; Casalini B; Koelsche C; Sievers P; Wefers AK; Reinhardt A; Ebrahimi A; Fernández-Klett F; Pusch S; Meier J; Schweizer L; Paulus W; Prinz M; Hartmann C; Plate KH; Reifenberger G; Pietsch T; Varlet P; Pagès M; Schüller U; Scheie D; de Stricker K; Frank S; Hench J; Pollo B; Brandner S; Unterberg A; Pfister SM; Jones DTW; Korshunov A; Wick W; Capper D; Blümcke I; von Deimling A; Bertero L
    Acta Neuropathol; 2019 May; 137(5):837-846. PubMed ID: 30759284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.
    Lehman NL; Usubalieva A; Lin T; Allen SJ; Tran QT; Mobley BC; McLendon RE; Schniederjan MJ; Georgescu MM; Couce M; Dulai MS; Raisanen JM; Al Abbadi M; Palmer CA; Hattab EM; Orr BA
    Acta Neuropathol Commun; 2019 Mar; 7(1):42. PubMed ID: 30876455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
    Bogumil H; Sill M; Schrimpf D; Ismer B; Blume C; Rahmanzade R; Hinz F; Cherkezov A; Banan R; Friedel D; Reuss DE; Selt F; Ecker J; Milde T; Pajtler KW; Schittenhelm J; Hench J; Frank S; Boldt HB; Kristensen BW; Scheie D; Melchior LC; Olesen V; Sehested A; Boué DR; Abdullaev Z; Satgunaseelan L; Kurth I; Seidlitz A; White CL; Ng HK; Shi ZF; Haberler C; Deckert M; Timmer M; Goldbrunner R; Tauziède-Espariat A; Varlet P; Brandner S; Alexandrescu S; Snuderl M; Aldape K; Korshunov A; Witt O; Herold-Mende C; Unterberg A; Wick W; Pfister SM; von Deimling A; Jones DTW; Sahm F; Sievers P
    Acta Neuropathol; 2023 May; 145(5):667-680. PubMed ID: 36933012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.
    Boisseau W; Euskirchen P; Mokhtari K; Dehais C; Touat M; Hoang-Xuan K; Sanson M; Capelle L; Nouet A; Karachi C; Bielle F; Guégan J; Marie Y; Martin-Duverneuil N; Taillandier L; Rousseau A; Delattre JY; Idbaih A
    Oncologist; 2019 Dec; 24(12):1584-1592. PubMed ID: 31346129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
    Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
    Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astroblastoma With a Novel YAP1::BEND2 Fusion: A Case Report.
    Cuoco JA; Williams S; Klein BJ; Borowicz VM; Ho H; Stump MS; Rogers CM
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):e313-e316. PubMed ID: 38857191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical heterogeneity of round cell sarcomas with EWSR1/FUS gene fusions: Impact of gene fusion type on clinical features and outcome.
    Tsuda Y; Zhang L; Meyers P; Tap WD; Healey JH; Antonescu CR
    Genes Chromosomes Cancer; 2020 Sep; 59(9):525-534. PubMed ID: 32362012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanding the spectrum of EWSR1-PATZ1 rearranged CNS tumors: An infantile case with leptomeningeal dissemination.
    Rossi S; Barresi S; Giovannoni I; Alesi V; Ciolfi A; Colafati GS; Diomedi-Camassei F; Miele E; Cacchione A; Quacquarini D; Carai A; Tartaglia M; Giannini C; Giangaspero F; Mastronuzzi A; Alaggio R
    Brain Pathol; 2021 May; 31(3):e12934. PubMed ID: 33378126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.